Variational Approximation Approaches for Efficient Clinical Predictions
Variational Approximation Approaches for Efficient Clinical Predictions
批准号:
MR/R024847/1
负责人:
DAVID HUGHES
金额:
$32.87万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Motivation: High-dimensional data is now routinely collected in many medical settings. The data may be high-dimensional due to the number of different variables being measured on a single patient (e.g. genetic or metabolomics studies) or the number of times a variable is repeatedly measured (e.g. longitudinal studies). In addition the number of individuals with available data in a study is now increasing (through the availability of Biobanks for example).One way in which this data can be used is in screening or monitoring patients to determine their risk of developing a disease or requiring an intervention, or to classify patients into various risk groups.Objective: In recent years joint models for multiple longitudinal (mainly continuous) and time-to-event data have been developed, which make use of mixed models. The popularity of these methods is evidenced by the success of software packages for joint models.These methods provide personalised predictions of a patient's risk of experiencing an event. However, a key limitation of current models is the computational burden required to fit such models. This burden occurs if there is a high number of patients (many thousands instead of a few hundred), many repeated observations per patient, or multiple clinical biomarkers under consideration. These factors have limited the uptake of joint-modelling methodology to generally small sample sizes and only a few (2-4) longitudinal biomarkers.In the machine learning literature variational approximation methods have been shown to give fast and accurate estimates of model parameters in a variety of settings. Recent statistical work has introduced these methods in univariate generalised linear mixed models, and in some genetic settings.My proposal is to derive a mean-field variational Bayes (MFVB) approach to estimating joint models for multiple longitudinal biomarkers of different type (continuous, counts, binary, etc.) and time-to-event data. The basic idea of the approach is to avoid estimating the model parameters from the full likelihood function but instead, split the likelihood function into a product of more tractable functions, which can then be more easily estimated. The rationale is that by sacrificing a little in terms of model accuracy, we gain the ability to fit multivariate joint model within a reasonable period of time (seconds/minutes instead of hours/days). Making it practicable to fit such models in a reasonable time frame, will allow personalised risk-prediction and diagnostics to be performed in real-time and make a substantial contribution towards stratified medical treatment and intelligent medical systems.Clinical Applications: The models developed will be used to assess the influence of covariates, and the correlation between at least 10 markers over time that have known links to a patient developing sight threatening diabetic retinopathy (STDR). Considering that the ISDR dataset contains over 20,000 patients, even fitting a univariate mixed model to assess the evolution over time is computationally intensive with current methods. Fitting a model to assess the correlation over time between all of these markers would be infeasible. My approach will lead to an improved understanding of the complex relationship between various clinical markers and their changes over time. I will derive personalised risk prediction models for STDR, which will provide increased understanding of risk factors and will provide patient specific assessment of their risk of STDR within clinically relevant timeframes. Some markers that appear to have a significant association in univariate analysis may be found to be no longer significant when multiple markers are considered. The models will allow us to inform clinicians as to the most crucial markers influencing risk of developing a disease and also to determine the best time to plan the patient's next visit.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Personalized risk-based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules.
基于个性化风险的糖尿病性视网膜筛查:一种多元方法与使用分层规则的使用。
DOI:
10.1111/dom.13552
发表时间:
2019-03
期刊:
Diabetes, obesity & metabolism
影响因子:
--
作者:
[García-Fiñana M, Hughes DM, Cheyne CP, Broadbent DM, Wang A, Komárek A, Stratton IM, Mobayen-Rahni M, Alshukri A, Vora JP, Harding SP]
通讯作者:
Harding SP
Performance of the Innova SARS-CoV-2 Antigen Rapid Lateral Flow Test in the Liverpool Asymptomatic Testing Pilot
Innova SARS-CoV-2 抗原快速侧向层析检测在利物浦无症状检测试点中的表现
DOI:
10.2139/ssrn.3798558
发表时间:
2021
期刊:
SSRN Electronic Journal
影响因子:
--
作者:
[García-Fiñana M]
通讯作者:
García-Fiñana M
DOI:
10.1016/s2213-2600(21)00175-2
发表时间:
2021-07
期刊:
The Lancet. Respiratory medicine
影响因子:
--
作者:
[Docherty AB, Mulholland RH, Lone NI, Cheyne CP, De Angelis D, Diaz-Ordaz K, Donegan C, Drake TM, Dunning J, Funk S, García-Fiñana M, Girvan M, Hardwick HE, Harrison J, Ho A, Hughes DM, Keogh RH, Kirwan PD, Leeming G, Nguyen Van-Tam JS, Pius R, Russell CD, Spencer RG, Tom BD, Turtle L, Openshaw PJ, Baillie JK, Harrison EM, Semple MG, ISARIC4C Investigators]
通讯作者:
ISARIC4C Investigators
Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: A cohort analysis of 2.7M people
通过疫苗接种状态、既往感染和邻里剥夺,通过 Delta 波和 Omicron 波改变 SARS-CoV-2 感染模式:对 270 万人进行的队列分析
DOI:
10.1101/2022.04.05.22273169
发表时间:
2022
期刊:
影响因子:
--
作者:
[Green M]
通讯作者:
Green M
DOI:
10.3390/molecules26113341
发表时间:
2021-06-02
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
[Frau A, Lett L, Slater R, Young GR, Stewart CJ, Berrington J, Hughes DM, Embleton N, Probert C]
通讯作者:
Probert C
共 8 条
海外基金